Testosterone supplementation in the aging male: Which0 questions have been answered?

Aging Male

Volumn 8, Issue 1, 2005, Pages 31-38

  Krause, Walter ^a   Mueller, Ulrich ^b   Mazur, Allan ^c  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c SYRACUSE UNIVERSITY   (United States)

Author keywords

Aging male; Organ functions; Substitution; Testosterone

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

AGED; BONE MASS; CARDIOVASCULAR PARAMETERS; COGNITION; CONFERENCE PAPER; HEMATOPOIESIS; HORMONE SUBSTITUTION; HUMAN; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; MALE; MEDLINE; MUSCLE MASS; PRIORITY JOURNAL; SEXUALITY;

ADULT; AGED; AGED, 80 AND OVER; AGING; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; TESTOSTERONE; UNITED STATES;

EID: 18844407559     PISSN: 13685538     EISSN: None     Source Type: Journal    
DOI: 10.1080/13685530500048872     Document Type: Conference Paper

References (46)

1. Tenover JL. In: Oddens B, Vermeulen A, editors. Androgens and the aging male. Parthenon Publishing; 1995.
2. Tenover JL. Testosterone replacement therapy in older adult men. Int J Androl 1999;22(5):300-306.
3. Janssens H, Vanderschueren DM. Endocrinological aspects of aging in men: is hormone replacement of benefit? Eur J Obstet Gynecol Reprod Biol 2000;92(1):7-12.
4. Hermann M, Berger P. Hormone replacement in the aging male? Exp Gerontol. 1999;34(8):923-933.
5. Juul A, Skakkebaek NE. Androgens and the ageing male. Hum Reprod Update 2002;8(5):423-433.
6. Morley JE, Perry HM 3rd. Andropause: an old concept in new clothing. Clin Geriatr Med 2003;19(3):507-528.
7. Vermeulen A. Diagnosis of partial androgen deficiency in the aging male. Ann Endocrinol (Paris) 2003;64(2):109-114.
8. Swerdloff RS, Wang C. Androgens an the aging male. In: Lunenfeld B, Gooren L, editors. Textbook of men's health. Parthenon Publishing; 2002.
9. Tenover JL. Androgens in older men. In: Bagatell CJ, Bremner WJ, editors. Androgens in health and disease. New Jersey: Humana Press; 2003.
10. Wu FC, Eckardstein A. Androgens and coronary artery diseases. In: Bagatell CJ, Bremner WJ, editors. Androgens in health and disease. New Jersey: Humana Press; 2003.
11. Szulc P, Claustrat B, Marchand F, Delmas PD. Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study. J Clin Endocrinol Metab 2003;88(11):5240-5247.
12. Gooren L. Visceral obesity, androgens and the risks of cardiovascular disease and diabetes mellitus. In: Lunenfeld B, Gooren L, editors. Textbook of men's health. Parthenon Publishing; 2002.
13. Crook D. Atherosclerotic risk assessment of androgen therapy in aging men. In: Lunenfeld B, Gooren L, editors. Textbook of men's health. Parthenon Publishing; 2002.
14. Kaufman JM. The effect of androgen supplementation therapy on the prostate. Aging Male 2003;6:166-174.
15. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf). 2003;58(5):632-638.
16. Cherrier MM, Craft S. Androgens and cognition. In: Bagatell CJ, Bremner WJ, editors. Androgens in health and disease. New Jersey: Humana Press; 2003.
17. Seidman SN, Spatz E, Rizzo C, Roose SP. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. J Clin Psychiatry 2001;62(6):406-412.
18. Pope HG Jr, Cohane GH, Kanayama G, Siegel AJ, Hudson JI. Testosterone gel supplementation for men with refractory depression: A randomized, placebo-controlled trial. Am J Psychiatry 2003;160(1):105-111.
19. Oddens B, Vermeulen A, editors. Androgens and the aging male. New York/London: Parthenon Publishing; 1996.
20. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 2001;56(5):M266-M2672.
21. Ng MK, Liu PY, Williams AJ, Nakhla S, Ly LP, Handelsman DJ, Celermajer DS. Prospective study of effect of androgens on serum inflammatory markers in men. Arterioscler Thromb Vasc Biol 2002;22(7):1136-1141.
22. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999;84(6):1966-1972.
23. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999;84(8):2647-2653.
24. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, et al. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf) 2001;54(6): 739-750.
25. Liu PY, Yee B, Wishart SM, Jimenez M, Jung DG, Grunstein RR, et al. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 2003;88(8):3605-3613.
26. Kenny AM, Prestwood KM, Gruman CA, Fabregas G, Biskup B, Mansoor G. Effects of transdermal testosterone on lipids and vascular reactivity in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 2002;57(7):M460-M465.
27. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 2000; 102(16):1906-1911.
28. Snyder PJ, Peachey H, Berlin JA, Rader D, Usher D, Loh L, et al. Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age. Am J Med 2001;111(4):255-260.
29. Brill KT, Weltman AL, Gentili A, Patrie JT, Fryburg DA, Hanks JB, et al. Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. J Clin Endocrinol Metab 2002;87(12):5649-5657.
30. Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 2003;6(1):1-7.
31. Herbst KL, Amory JK, Brunzell JD, Chansky HA, Bremner WJ. Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk. Am J Physiol Endocrinol Metab 2003;284(6):E1112-E1118.
32. Schroeder ET, Singh A, Bhasin S, Storer TW, Azen C, Davidson T, et al. Effects of an oral androgen on muscle and metabolism in older, community-dwelling men. Am J Physiol Endocrinol Metab 2003;284(1):E120-E128.
33. Wang C, Swedloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group. J Clin Endocrinol Metab 2000;85(8):2839-2853.
34. Lambert CP, Sullivan DH, Freeling SA, Lindquist DM, Evans WJ. Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate stimulated weight gain in elderly men: a randomized controlled trial. J Clin Endocrinol Metab 2002;87(5): 2100-2106.
35. Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 2002; 282(3):E601-E607.
36. Crawford BA, Liu PY, Kean MT, Bleasel JF, Handelsman DJ. Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. J Clin Endocrinol Metab 2003; 88(7):3167-3176.
37. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci 2003;58(7):618-625.
38. McNicholas TA, Dean JD, Mulder H, Carnegie C, Jones NA. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int 2003;91(1):69-74.
39. Steidle C, Schwartz S, Jacoby K, Sebree T, Smith T, Bachand R. North American AA2500 T Gel Study Group. AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab 2003;88(6):2673-2681.
40. Rhoden EL, Morgentaler A. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia. J Urol 2003;170(6 Pt 1):2348-2351.
41. Cherrier MM, Asthana S, Plymate S, Baker L, Matsumoto AM, Peskind E, et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001;57(1):80-88.
42. Kenny AM, Fabregas G, Song C, Biskup B, Bellantonio S. Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci 2004;59(1):75-78.
43. Wolf OT, Preut R, Hellhammer DH, Kudielka BM, Schurmeyer TH, Kirschbaum C. Testosterone and cognition in elderly men: a single testosterone injection blocks the practice effect in verbal fluency, but has no effect on spatial or verbal memory. Biol Psychiatry 2000;47(7):650-654.
44. Kenny AM, Bellantonio S, Gruman CA, Acosta RD, Prestwood KM. Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 2002;57(5):M321-M325.
45. Perry PJ, Yates WR, Williams RD, Andersen AE, MacIndoe JH, Lund BC, et al. Testosterone therapy in late-life major depression in males. J Clin Psychiatry 2002;63(12): 1096-1101.
46. Reddy P, White CM, Dunn AB, Moyna NM, Thompson PD. The effect of testosterone on health-related quality of life in elderly males - a pilot study. J Clin Pharm Ther 2000; 25(6):421-426.